248 related articles for article (PubMed ID: 29061946)
1. Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma.
Dickerson EB; Bryan BA
Vet Sci; 2015 Sep; 2(3):270-292. PubMed ID: 29061946
[TBL] [Abstract][Full Text] [Related]
2. Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions.
Kim JH; Megquier K; Thomas R; Sarver AL; Song JM; Kim YT; Cheng N; Schulte AJ; Linden MA; Murugan P; Oseth L; Forster CL; Elvers I; Swofford R; Turner-Maier J; Karlsson EK; Breen M; Lindblad-Toh K; Modiano JF
Mol Cancer Res; 2021 May; 19(5):847-861. PubMed ID: 33649193
[TBL] [Abstract][Full Text] [Related]
3. Hemangiosarcoma Cells Promote Conserved Host-Derived Hematopoietic Expansion.
Kim JH; Schulte AJ; Sarver AL; Lee D; Angelos MG; Frantz AM; Forster CL; O'Brien TD; Cornax I; O'Sullivan MG; Cheng N; Lewellen M; Oseth L; Kumar S; Bullman S; Pedamallu CS; Goyal SM; Meyerson M; Lund TC; Breen M; Lindblad-Toh K; Dickerson EB; Kaufman DS; Modiano JF
Cancer Res Commun; 2024 May; ():. PubMed ID: 38757809
[TBL] [Abstract][Full Text] [Related]
4. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
[TBL] [Abstract][Full Text] [Related]
5. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
Stiles JM; Amaya C; Rains S; Diaz D; Pham R; Battiste J; Modiano JF; Kokta V; Boucheron LE; Mitchell DC; Bryan BA
PLoS One; 2013; 8(3):e60021. PubMed ID: 23555867
[TBL] [Abstract][Full Text] [Related]
6. Machine learning application identifies novel gene signatures from transcriptomic data of spontaneous canine hemangiosarcoma.
Cheng N; Schulte AJ; Santosa F; Kim JH
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33078825
[TBL] [Abstract][Full Text] [Related]
7. Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma.
Kurisetty V; Bryan BA
Angiol Open Access; 2013 Apr; 1():. PubMed ID: 25374893
[TBL] [Abstract][Full Text] [Related]
8. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
Fanburg-Smith JC; Furlong MA; Childers EL
Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
[TBL] [Abstract][Full Text] [Related]
9. Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.
Chow W; Amaya CN; Rains S; Chow M; Dickerson EB; Bryan BA
JAMA Dermatol; 2015 Nov; 151(11):1226-9. PubMed ID: 26375166
[TBL] [Abstract][Full Text] [Related]
10. Actionable mutations in canine hemangiosarcoma.
Wang G; Wu M; Maloneyhuss MA; Wojcik J; Durham AC; Mason NJ; Roth DB
PLoS One; 2017; 12(11):e0188667. PubMed ID: 29190660
[TBL] [Abstract][Full Text] [Related]
11. Angiosarcomas and other sarcomas of endothelial origin.
Cioffi A; Reichert S; Antonescu CR; Maki RG
Hematol Oncol Clin North Am; 2013 Oct; 27(5):975-88. PubMed ID: 24093171
[TBL] [Abstract][Full Text] [Related]
12. Claudin-5 protein is a new differential marker for histopathological differential diagnosis of canine hemangiosarcoma.
Jakab C; Halász J; Kiss A; Schaff Z; Rusvai M; Gálfi P; Abonyi TZ; Kulka J
Histol Histopathol; 2009 Jul; 24(7):801-13. PubMed ID: 19475526
[TBL] [Abstract][Full Text] [Related]
13. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.
Pasquier E; André N; Street J; Chougule A; Rekhi B; Ghosh J; Philip DSJ; Meurer M; MacKenzie KL; Kavallaris M; Banavali SD
EBioMedicine; 2016 Apr; 6():87-95. PubMed ID: 27211551
[TBL] [Abstract][Full Text] [Related]
14. Histopathological Grading, Clinical Staging and CD 31 Expression of Canine Splenic Hemangiosarcoma.
Chu KT; Nekouei O; Sandy JR
Vet Sci; 2023 Mar; 10(3):. PubMed ID: 36977229
[TBL] [Abstract][Full Text] [Related]
15. Optimal Clinical Management and the Molecular Biology of Angiosarcomas.
Chen TW; Burns J; Jones RL; Huang PH
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182685
[TBL] [Abstract][Full Text] [Related]
16. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
Tokuyama W; Mikami T; Masuzawa M; Okayasu I
Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
[TBL] [Abstract][Full Text] [Related]
17. Angiosarcoma of the Liver: Clinicopathologic Features and Morphologic Patterns.
Yasir S; Torbenson MS
Am J Surg Pathol; 2019 May; 43(5):581-590. PubMed ID: 30986799
[TBL] [Abstract][Full Text] [Related]
18. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Liau JY; Tsai JH; Yang CY; Lee JC; Liang CW; Hsu HH; Jeng YM
Hum Pathol; 2015 Sep; 46(9):1360-6. PubMed ID: 26190196
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals.
Schultheiss PC
J Vet Diagn Invest; 2004 Nov; 16(6):522-6. PubMed ID: 15586567
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal drug sequestration as a mechanism of drug resistance in vascular sarcoma cells marked by high CSF-1R expression.
Gorden BH; Saha J; Khammanivong A; Schwartz GK; Dickerson EB
Vasc Cell; 2014; 6():20. PubMed ID: 25295160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
